Science Explorer Back to mapMap
Discussion
Company · La Jolla · United States

Ambrx (United States)

Research works
36
▲ 112% vs 2018-21
Citations
1.2k
34.8 per fractional work
Top-10% rate
13.2%
all institutions 10.0%
Open access
39%
world 40%
International
12%
world 18%

Not ranked overall: Ambrx (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Ambrx (United States) work in?

In all years, 58% of research at Ambrx (United States) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (29%), Immunology and Microbiology (4%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 21 fractional works · 57.8% of its workMedicine: 20 fractional works · 55.7% of its workRadiology, Nuclear Medicine and Imaging: 8 fractional works · 21.4% of its workOncology: 7 fractional works · 19.3% of its workPulmonary and Respiratory Medicine: 2 fractional works · 4.7% of its workImmunology and Allergy: 1 fractional works · 2.7% of its workPathology and Forensic Medicine: 1 fractional works · 1.9% of its workEpidemiology: 1 fractional works · 1.6% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.5% of its workHematology: 0 fractional works · 1.0% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.9% of its workRheumatology: 0 fractional works · 0.6% of its workNursing: 1 fractional works · 2.0% of its workNutrition and Dietetics: 1 fractional works · 2.0% of its workLife Sciences: 12 fractional works · 34.2% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 29.1% of its workMolecular Biology: 7 fractional works · 20.0% of its workGenetics: 1 fractional works · 3.3% of its workBiotechnology: 1 fractional works · 3.3% of its workCancer Research: 1 fractional works · 2.6% of its workImmunology and Microbiology: 2 fractional works · 4.3% of its workImmunology: 1 fractional works · 3.9% of its workVirology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.3% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 4.0% of its workSocial Sciences: 1 fractional works · 2.8% of its workLaw: 1 fractional works · 2.8% of its workBusiness, Management and Accounting: 0 fractional works · 1.2% of its workManagement Information Systems: 0 fractional works · 0.6% of its workStrategy and Management: 0 fractional works · 0.6% of its workPhysical Sciences: 1 fractional works · 4.0% of its workChemistry: 1 fractional works · 2.1% of its workOrganic Chemistry: 1 fractional works · 1.9% of its workInorganic Chemistry: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 1.1% of its workArtificial Intelligence: 0 fractional works · 0.6% of its workHuman-Computer Interaction: 0 fractional works · 0.5% of its workMaterials Science: 0 fractional works · 0.5% of its workBiomaterials: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.2% of its workEngineering: 0 fractional works · 0.2% of its workAutomotive Engineering: 0 fractional works · 0.2% of its workALL ITS WORKAmbrx (UnitedStates)36fractional works, all years
Life Sciences34%Physical Sciences4%Health Sciences58%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine2055.7%
    2. Nursing12.0%
    1. Biochemistry, Genetics and Molecular Biology1029.1%
    2. Immunology and Microbiology24.3%
    3. Agricultural and Biological Sciences00.3%
    4. Neuroscience00.3%
    5. Pharmacology, Toxicology and Pharmaceutics00.2%
    1. Social Sciences12.8%
    2. Business, Management and Accounting01.2%
    1. Chemistry12.1%
    2. Computer Science01.1%
    3. Materials Science00.5%
    4. Engineering00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.21× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.62× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 6.16× its world share, 1 worksImmunology and Micro…Computer Science: 0.45× its world share, 0 worksComputer ScienceEngineering: 0.05× its world share, 0 worksEngineeringMedicine: 3.21× its world share, 7 worksMedicineBusiness, Management and Accounting: 1.24× its world share, 0 worksBusiness, Management…Social Sciences: 0.71× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.2×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Immunology and Microbiology6.16×1 works
  2. Medicine3.21×7 works
  3. Biochemistry, Genetics and Molecular Biology2.62×2 works
  4. Business, Management and Accounting1.24×0 works
  5. Social Sciences0.71×1 works
  6. Computer Science0.45×0 works
  7. Agricultural and Biological Sciences0.21×0 works
  8. Engineering0.05×0 works

Who are the top researchers at Ambrx (United States)?

Ranked on the quality score, Sandra Lyn Biroc, Nick A. Knudsen and Jason K. Pinkstaff lead among researchers whose main affiliation is Ambrx (United States).

  1. 1 Sandra Lyn Biroc United States · #602,779 worldwide 2.7k citations · 41 works
  2. 2 Nick A. Knudsen United States · #619,001 worldwide 867 citations · 31 works
  3. 3 Jason K. Pinkstaff United States · #788,842 worldwide 2.3k citations · 41 works
  4. 4 Anthony Manibusan United States · #870,614 worldwide 1.1k citations · 20 works
  5. 5 Lillian K. Skidmore United States · #1,282,039 worldwide 438 citations · 47 works
All ranked researchers at Ambrx (United States)

What are the most cited papers from Ambrx (United States)?

The most cited paper from Ambrx (United States) is "Synthesis of site-specific antibody-drug conjugates using unnatural amino acids" (Jun Y. Axup et al., 2012), with 594 citations. Next come "A general approach to site-specific antibody drug conjugates" (320) and "Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases" (198).

Most cited papers
#PaperReleasedCitations
1 Synthesis of site-specific antibody-drug conjugates using unnatural amino acids Jun Y. Axup et al. · Proceedings of the National Academy of Sciences Open access 17 Sep 2012 594
2 A general approach to site-specific antibody drug conjugates Feng Tian et al. · Proceedings of the National Academy of Sciences Open access 17 Jan 2014 320
3 Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases Natsuko Nomura, Sandra Pastorino, Pengfei Jiang et al. · Cancer Cell International Open access 19 Mar 2014 198
4 Optimized clinical performance of growth hormone with an expanded genetic code Ho Cho et al. · Proceedings of the National Academy of Sciences Open access 16 May 2011 198
5 ARX788, a Site-specific Anti-HER2 Antibody–Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1–resistant Breast and Gastric Cancers Lillian K. Skidmore, Sukumar Sakamuri, Nick A. Knudsen et al. · Molecular Cancer Therapeutics 15 Jul 2020 166
All 48 most cited papers, with filters and sorting

Which keywords describe research at Ambrx (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Glycosylation, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Monoclonal Antibody, Breast Cancer and Chemotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Monoclonal Antibodies7▲ 140×3 topics
  2. Glycosylation7▲ 84×3 topics
  3. Therapeutic Antibodies6▲ 142×2 topics
  4. Antibody Engineering6▲ 165×1 topic
  5. Fc Receptors6▲ 165×1 topic
  6. Monoclonal Antibody5▲ 189×2 topics
  7. Breast Cancer5▲ 46×2 topics
  8. Chemotherapy4▲ 17×2 topics
  9. HER24▲ 388×1 topic
  10. Trastuzumab4▲ 275×1 topic
  11. Immunotherapy4▲ 15×5 topics
  12. Cancer2▲ 5.0×10 topics
  13. PET Imaging2▲ 31×2 topics
  14. Tumor Regression2▲ 74×2 topics
  15. Lymphoma2▲ 37×2 topics
  16. Inflammation2▲ 2.3×8 topics
  17. Cancer Treatment2▲ 19×2 topics
  18. Targeted Therapy2▲ 23×2 topics
  19. Gene Therapy2▲ 18×4 topics
  20. Radioimmunotherapy2▲ 123×1 topic
  21. Radiopharmaceuticals2▲ 123×1 topic
  22. Cancer Therapy2▲ 7.0×3 topics
  23. Cancer Immunotherapy1▲ 27×2 topics
  24. Angiogenesis1▲ 9.1×4 topics
  25. Apoptosis1▲ 9.4×2 topics
  26. Biopharmaceuticals1▲ 52×2 topics
  27. CAR T Cells1▲ 84×1 topic
  28. Chimeric Antigen Receptor1▲ 84×1 topic
  29. Immunogenicity1▲ 70×2 topics
  30. Self-Assembly1▲ 9.1×2 topics
  31. Biosensors1▲ 5.9×1 topic
  32. DNA nanotechnology1▲ 33×1 topic
  33. Extracellular Matrix1▲ 12×2 topics
  34. Bacterial Therapy1▲ 64×1 topic
  35. Cell Death1▲ 14×2 topics
  36. Constitutional Law1▲ 21×1 topic
  37. Genetic Mutations1▲ 5.4×2 topics
  38. Human Rights1▲ 3.3×1 topic
  39. Mitochondria1▲ 17×2 topics
  40. Tumor Targeting1▲ 21×1 topic

Which research topics does Ambrx (United States) publish most on?

By volume in 2022-now: Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and Brazilian Legal Issues.

  1. 1 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 HER2/EGFR in Cancer Research Oncology 1 works
  4. 4 Brazilian Legal Issues Law 1 works
  5. 5 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
  6. 6 CAR-T cell therapy research Oncology 1 works
  7. 7 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  8. 8 Protein purification and stability Molecular Biology 0 works
  9. 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  10. 10 Immune Cell Function and Interaction Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.7%not open61.3%

World: 40% of research is openly available.

with international co-authors12.4%domestic only87.6%

World: 18% is written across borders.

How has Ambrx (United States)'s research output changed?

Output in 2022-2025 was 112% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Ambrx (United States) as a percentage of every work published that year, 0.000031% in 2024.

still counting0.00010%0.00020%Ambrx (United States)0.000026% in 202520102020

Fractional works of Ambrx (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in La Jolla

All research institutions in La Jolla

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Ambrx (United States). Posts are plain text and can be reported.